ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Themes
      • Active ETF
      • Artificial Intelligence
      • Beyond Basic Beta
      • China Insights
      • Climate Insights
      • Core Strategies
      • Crypto
      • Disruptive Technology
      • Energy Infrastructure
      • ETF Building Blocks
      • ETF Investing
      • ETF Education
      • ETF Strategist
      • Financial Literacy
      • Fixed Income
      • Free Cash Flow
      • Innovative ETFs
      • Institutional Income Strategies
      • Leveraged & Inverse
      • Managed Futures
      • Market Insights
      • Modern Alpha
      • Responsible Investing
      • Retirement Income
      • Tax Efficient Income
    • Asset Class
      • Equity
        • U.S. Equity
        • Int'l Developed
        • Emerging Market Equities
      • Alternatives
        • Commodities
        • Gold/Silver/Critical Minerals
        • Currency
        • Volatility
      • Fixed Income
        • Investment Grade Corporates
        • US Treasuries & TIPS
        • High Yield Corporates
        • Int'l Fixed Income
    • ETF Ecosystem
    • ETFs in Canada
    • Market Outlook Channel
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. Disruptive Technology Channel
  2. Innovation Is Crucial to Healthcare Long-Term Growth
Disruptive Technology Channel
Share

Innovation Is Crucial to Healthcare Long-Term Growth

Tom LydonMar 23, 2023
2023-03-23

Experienced healthcare investors know several important facts regarding large-cap, blue-chip biopharma companies.

First, these firms enjoy a limited amount of time when their blockbuster drugs corner a specific niche. Then, patent protections expire and generic competitors can join the party. Second, that creates pressure to ensure that pipelines are full with new potential blockbusters. Third, one of way of accomplishing that goal is through mergers and acquisitions.

All of that is to say that innovation in the healthcare sector is critical. Clinicians, investors, and patients realize as much. Among exchange traded funds, the ARK Genomic Revolution ETF (ARKG A-) is arguably a bastion of healthcare innovation, perhaps making an appropriately timed option for investors looking to skirt some of the aforementioned issues facing old guard biopharma firms. Consider the case of sales lost to generic competitors.

“Over the next five years, we expect erosion in sales from expired or expiring patents to result in a $100 billion headwind. We do think this loss will be roughly matched by growth of other approved drugs as they expand market share and gain approval in new indications. Growth will be determined by the contribution from pipeline products,” according to Morningstar.

Importantly, ARKG is actively managed, meaning the fund can be swift to alter allocations to capitalize on critical trends in the healthcare sector. Those include rising demand for breast and blood cancer treatments and more broad oncology fare. In fact, cell therapy and gene-based approaches — concepts some ARKG member firms address — are viewed as critical drivers of oncology advancements.

“In oncology, industry investment has been high owing to significant unmet need and strong pricing power. IQVIA forecasts oncology as the fastest-growing area of drug spending, with double-digit growth pushing spending up to $377 billion in 2027 (from $193 billion in 2022),” added Morningstar.

ARKG is a relevant choice for tactical healthcare investors for another reason: Its components aren’t reliant on coronavirus vaccines to drive top-line growth. While that trait worked against the ETF in 2021 and last year, it could be a positive going forward because data indicate waning appetite for COVID-19 vaccines. That diminished demand likely means lower revenue for producers.

“We expect the nearly $100 billion vaccine market to contract in 2023 because of less need for COVID vaccines but then steadily increase. Despite the remarkable speed to market for COVID vaccines, vaccine development tends to take several years longer than drug development, and manufacturing is much more complex, which generally leaves only one or two vaccines per market,” concluded Morningstar.

For more news, information, and analysis, visit our Disruptive Technology Channel.

Loading Articles...
Our Sites
  • VettaFi
  • Advisor Perspectives
  • ETF Trends
Tools
  • ETF Screener
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Database Pro
More Tools
  • Financial Advisor & RIA Center
Explore ETFs
  • ETF News
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Information
  • Contact Us
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X